Delivery Order SPE2DB22D3401-SPE2DB25FT5XN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,601.50 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and utilized firm fixed pricing under a non-set-aside, competitive procurement process. Performance of this delivery order is based in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Fosfomycin 3 GM sachets under a firm fixed price contract with a ceiling value of $1,042.36. This delivery order, which is set to be completed by July 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis, reflecting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,287.23 firm fixed price delivery order is for the provision of 4,564,085,519 units of the antibiotic medication Fosfomycin 3 GM Sachets. The award is associated with a larger indefinite delivery contract (IDC)...
- This is a delivery order (SPE2DB22D3016|SPE2DB24FBFK9) awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp for the supply of 4,565,618,229 units of Fosfomycin 3 GM sachets. The contract has a ceiling value of $1,120.23 and is a firm fixed price contract. The period of performance extends through August 29, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,146.64, is for the delivery of 4,567,909,932 units of Fosfomycin 3 GM Sachets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $41,490 to Amerisourcebergen Drug Corporation for 4561919606 fosfomycin 3 gm sachets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania within the period of performance from August 23 to August 24, 2023. The Defense Logistics Agency Troop Support Medical supports the medical...
- The Defense Logistics Agency awarded a $248,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 3 gram sachets of fosfomycin. As a prime contractor on the Agency's Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle, Amerisourcebergen will supply the antibiotic medication to DLA distribution points in Conshohocken, Pennsylvania from August 24-25, 2023. No subcontractors or set aside designations were specified. This supports DLA's mission to...
- The Defense Logistics Agency awarded a $1,147 delivery order to Amerisourcebergen Drug Corporation for 4561866200 fosfomycin 3 gm sachets. The firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three-day period concluding on August 21, 2023. No set aside designation or subcontractors were...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed-price delivery order valued at approximately $1,079 to provide 3 gram sachets of fosfomycin. As the prime contractor, Amerisourcebergen will deliver the antibiotic medication to its place of performance in Conshohocken, Pennsylvania by July 26, 2023 in fulfillment of this requirement. The Defense Logistics Agency functions to support military readiness by procuring and providing logistics support for the...
- The Defense Logistics Agency Troop Support Medical awarded a $851 firm fixed price delivery order to Amerisourcebergen Drug Corp for 3 gram sachets of fosfomycin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the one day period of September 6-7, 2023. The contract was awarded under the Medical Prime Vendor Program, a strategic sourcing initiative utilized by DLA Troop...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5XNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,002.72 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. Fosfomycin is an antibiotic medication used to treat bacterial infections and is a critical component of military medical supply chains. As the prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen leverages its comprehensive global pharmaceutical support vehicle to fulfill federal medical procurement requirements across multiple therapeutic domains. This contract award demonstrates the company's continued role as a primary pharmaceutical distributor for the Defense Health Agency and other military healthcare systems, with no set-aside designation applied to this competitive award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/28/25 |